Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB

Human Molecular Genetics

Volumn 22, Issue 17, 2013, Pages 3438-3448

  Uebelhoer, Melanie ^a   Nätynki, Marjut ^d   Kangas, Jaakko ^d   Mendola, Antonella ^a   Nguyen, Ha Long ^a   Soblet, Julie ^a   Godfraind, Catherine ^b   Boon, Laurence M ^a,c   Eklund, Lauri ^d   Limaye, Nisha ^a   Vikkula, Miikka ^a,c  

^a DE DUVE INSTITUTE   (Belgium)

^b Neuroscience Center   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MUTANT PROTEIN; PLATELET DERIVED GROWTH FACTOR B; PROTEIN KINASE B; STAT1 PROTEIN; TRANSCRIPTION FACTOR FKHR;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; EX VIVO STUDY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOMATIC MUTATION; VASCULAR SMOOTH MUSCLE; VEIN MALFORMATION; WESTERN BLOTTING;

EID: 84881590742     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt198     Document Type: Article

References (36)

1. Calvert, J.T., Riney, T.J., Kontos, C.D., Cha, E.H., Prieto, V.G., Shea, C.R., Berg, J.N., Nevin, N.C., Simpson, S.A., Pasyk, K.A. et al. (1999) Allelic and locus heterogeneity in inherited venous malformations.Hum. Mol. Genet., 8, 1279-1289.
2. Limaye, N., Wouters, V., Uebelhoer, M., Tuominen, M., Wirkkala, R., Mulliken, J.B., Eklund, L., Boon, L.M. and Vikkula, M. (2009) Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat. Genet., 41, 118-124.
3. Nobuhara, Y., Onoda, N., Fukai, K., Hosomi, N., Ishii, M., Wakasa, K., Nishihara, T., Ishikawa, T., Hirakawa, K. (2006) TIE2 gain-of-function mutation in a patient with pancreatic lymphangioma associated with blue rubber-bleb nevus syndrome: report of a case. Surg. Today, 36, 283-286.
4. Soblet, J., Limaye, N., Uebelhoer, M., Dompmartin, A., Vanwijck, R., Boon, L.M., Vikkula, M. Variable somatic TIE2 mutations in half of sporadic venous malformations. J. Mol. Syndromol., in press, doi 10.1159/ 000348327.
5. Vikkula, M., Boon, L.M., Carraway, K.L. III, Calvert, J.T., Diamonti, A.J., Goumnerov, B., Pasyk, K.A., Marchuk, D.A., Warman, M.L., Cantley, L.C., et al. (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell, 87, 1181-1190.
6. Wouters, V., Limaye, N., Uebelhoer, M., Irrthum, A., Boon, L.M., Mulliken, J.B., Enjolras, O., Baselga, E., Berg, J., Dompmartin, A., et al. (2010) Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur. J. Hum. Genet., 18, 414-420
7. Morris, P.N., Dunmore, B.J., Tadros, A., Marchuk, D.A., Darland, D.C., D'Amore, P.A., Brindle, N.P. (2005) Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations. J. Mol. Med. (Berl.), 83, 58-63.
8. Korpelainen, E.I., Karkkainen, M., Gunji, Y., Vikkula, M., Alitalo, K. (1999) Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene, 18, 1-8.
9. Hu, H.T., Huang, Y.H., Chang, Y.A., Lee, C.K., Jiang, M.J., Wu, L.W. (2008) Tie2-R849W mutant in venous malformations chronically activates a functional STAT1 to modulate gene expression. J. Invest. Dermatol., 128, 2325-2333.
10. Huang, Y.H., Wu, M.P., Pan, S.C., Su, W.C., Chen, Y.W., Wu, L.W. (2013) STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production. Angiogenesis, 16, 207-222.
11. Fukuhara, S., Sako, K., Minami, T., Noda, K., Kim, H.Z., Kodama, T., Shibuya, M., Takakura, N., Koh, G.Y., Mochizuki, N. (2008) Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat. Cell Biol., 10, 513-526.
12. Saharinen, P., Eklund, L., Miettinen, J., Wirkkala, R., Anisimov, A., Winderlich, M., Nottebaum, A., Vestweber, D., Deutsch, U., Koh, G.Y., et al. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell Biol., 10, 527-537.
13. Kim, I., Kim, H.G., So, J.N., Kim, J.H., Kwak, H.J., Koh, G.Y. (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ. Res., 86, 24-29.
14. Papapetropoulos, A., Fulton, D., Mahboubi, K., Kalb, R.G., O'Connor, D.S., Li, F., Altieri, D.C., Sessa, W.C. (2000) Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J. Biol. Chem., 275, 9102-9105.
15. Yoon, M.J., Cho, C.H., Lee, C.S., Jang, I.H., Ryu, S.H., Koh, G.Y. (2003) Localization of Tie2 and phospholipase D in endothelial caveolae is involved in angiopoietin-1-induced MEK/ERK phosphorylation and migration in endothelial cells. Biochem. Biophys. Res. Commun., 308, 101-105.
16. Brigstock, D.R. (2002) Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis, 5, 153-165.
17. Fischer, C., Mazzone, M., Jonckx, B., Carmeliet, P. (2008) FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat. Rev. Cancer, 8, 942-956.
18. Suzuki, Y., Montagne, K., Nishihara, A., Watabe, T., Miyazono, K. (2008) BMPs promote proliferation and migration of endothelial cells via stimulation of VEGF-A/VEGFR2 and angiopoietin-1/Tie2 signalling. J. Biochem., 143, 199-206.
19. Zhou, Q., Heinke, J., Vargas, A., Winnik, S., Krauss, T., Bode, C., Patterson, C., Moser, M. (2007) ERK signaling is a central regulator for BMP-4 dependent capillary sprouting. Cardiovasc. Res., 76, 390-399.
20. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N., et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 277, 55-60.
21. Armstrong, L.C., Bornstein, P. (2003)Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol., 22, 63-71.
22. Lin, E.A., Liu, C.J. (2010) The role of ADAMTSs in arthritis. Protein Cell, 1, 33-47.
23. Porter, S., Clark, I.M., Kevorkian, L., Edwards, D.R. (2005) The ADAMTS metalloproteinases. Biochem. J., 386, 15-27.
24. Essaghir, A., Toffalini, F., Knoops, L., Kallin, A., van Helden, J., Demoulin, J.B. (2010) Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data. Nucleic Acids Res., 38, e120.
25. Daly, C., Wong, V., Burova, E., Wei, Y., Zabski, S., Griffiths, J., Lai, K.M., Lin, H.C., Ioffe, E., Yancopoulos, G.D., et al. (2004) Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev., 18, 1060-1071.
26. Potente, M., Urbich, C., Sasaki, K., Hofmann, W.K., Heeschen, C., Aicher, A., Kollipara, R., DePinho, R.A., Zeiher, A.M., Dimmeler, S. (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest., 115, 2382-2392.
27. Brouillard, P., Boon, L.M., Mulliken, J.B., Enjolras, O., Ghassibe, M., Warman, M.L., Tan, O.T., Olsen, B.R., Vikkula, M. (2002) Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ('glomangiomas'). Am. J. Hum. Genet., 70, 866-874.
28. Hosaka, T., Biggs, W.H. III, Tieu, D., Boyer, A.D., Varki, N.M., Cavenee, W.K., Arden, K.C. (2004) Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl Acad. Sci. USA, 101, 2975-2980.
29. Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., Betsholtz, C. (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development, 126, 3047-3055.
30. Lindahl, P., Johansson, B.R., Leveen, P., Betsholtz, C. (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science, 277, 242-245.
31. Hellstrom, M., Gerhardt, H., Kalen, M., Li, X., Eriksson, U., Wolburg, H., Betsholtz, C. (2001) Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol., 153, 543-553.
32. Soriano, P. (1994) Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev., 8, 1888-1896.
33. Li, L., Blumenthal, D.K., Masaki, T., Terry, C.M., Cheung, A.K. (2006) Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cells. J. Cell Biochem., 99, 1553-1563.
34. Li, L., Blumenthal, D.K., Terry, C.M., He, Y., Carlson, M.L., Cheung, A.K. (2011) PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoforms. J. Cell Biochem., 112, 289-298.
35. Redondo, P., Aguado, L., Marquina, M., Paramo, J.A., Sierra, A., Sanchez-Ibarrola, A., Martinez-Cuesta, A., Cabrera, J. (2010) Angiogenic and prothrombotic markers in extensive slow-flow vascular malformations: implications for antiangiogenic/antithrombotic strategies. Br. J. Dermatol., 162, 350-356.
36. Ory, D.S., Neugeboren, B.A., Mulligan, R.C. (1996) A stable human-derived packaging cell line for production of high titer retrovirus/ vesicular stomatitis virus G pseudotypes. Proc. Natl Acad. Sci. USA, 93, 11400-11406.